The Comprehensive Cushing Syndrome Workup Guide
The Comprehensive Cushing Syndrome Workup Guide Cushing syndrome, a complex endocrine disorder characterized by excessive cortisol production, demands a meticulous and systematic diagnostic approach. Proper identification of the underlying cause is crucial, as treatment strategies vary significantly depending on whether the excess cortisol is due to endogenous overproduction or exogenous sources. The comprehensive workup begins with a detailed clinical assessment, followed by a series of laboratory and imaging studies that help confirm the diagnosis and pinpoint the origin of cortisol excess.
Initial evaluation involves a thorough history and physical examination. Patients often present with features such as central obesity, purple striae, a rounded face (moon face), dorsocervical fat pad (buffalo hump), muscle weakness, hypertension, and glucose intolerance. A history of exogenous corticosteroid use must be meticulously documented, as it is a common cause of iatrogenic Cushing syndrome. The clinician should also evaluate for signs of comorbidities, including osteoporosis, skin thinning, and psychiatric disturbances.
Biochemical testing is essential to confirm hypercortisolism. The first-line screening tests include late-night salivary cortisol, 24-hour urinary free cortisol, and the low-dose dexamethasone suppression test. Each has its advantages: late-night salivary cortisol offers convenience and high sensitivity, while 24-hour urinary cortisol provides a comprehensive measure of cortisol secretion over a full day. The low-dose dexamethasone suppression test involves administering 1 mg of dexamethasone overnight and measuring serum cortisol the following morning; failure to suppress indicates hypercortisolism.
Once biochemical confirmation is established, establishing whether the hypercortisolism is ACTH-dependent or independent guides further workup. Measurement of plasma ACTH levels is pivotal. A low or undetectable ACTH suggests an adrenal cause, while elevated or inappropriately normal ACTH indicates an ACTH-dependent process,
which could be a pituitary adenoma (Cushing disease) or ectopic ACTH secretion from tumors such as small cell lung carcinoma or carcinoids.
Suppose ACTH is elevated; dynamic testing with high-dose dexamethasone suppression or corticotropin-releasing hormone (CRH) stimulation can differentiate between pituitary and ectopic sources. In most cases, a high-dose dexamethasone suppression test shows suppression of cortisol in Cushing disease but not in ectopic ACTH syndrome. MRI imaging of the pituitary gland is subsequently performed to identify a possible adenoma. For ectopic sources, imaging modalities such as CT scans of the chest and abdomen are employed to locate potential tumors.
If ACTH is suppressed, adrenal imaging with CT or MRI helps identify adrenal tumors or hyperplasia. Additional tests like adrenal venous sampling may be necessary in complex cases to distinguish between unilateral adenomas and bilateral hyperplasia.
The workup concludes with targeted imaging and sometimes invasive procedures, depending on the suspected etiology. Collaboration among endocrinologists, radiologists, and surgeons is essential to formulate an effective treatment plan. This comprehensive approach ensures accurate diagnosis, guiding definitive therapy—whether surgical removal of adrenal or pituitary tumors, or managing ectopic sources—ultimately improving patient outcomes.